广生堂：
尊敬的投资者您好。GST-HG141的II期研究结果发表于《柳叶刀一eClinicalMedicine》，论文名称为《Safety and efficacy of GST-HG141, a novel HBV capsid assembly modulator, for the treatment of chronic hepatitis B patients with low-level viremia: a randomized, double-blind,placebo-controlled, multicenter phase ll study》。感谢您对公司的关注和支持。